The first round of pandemic-era guidance documents to be retired after the May ending of the public health emergency are no longer in effect, the US Food and Drug Administration announced on 8 November.
The 16 policies being put to bed largely allowed enforcement discretion for a range of products that were in high demand during the pandemic, such as imaging systems, digital health devices to treat psychiatric conditions, face shields, infusion pumps, ventilators and accessories, as well as sterilizers and air purifiers. A full list is in the March guidance document, “
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?